21 related news articles for Signal Transduction in Cancer Biology

Hudson Institute research has been recognised in this year’s National Health and Medical Research Council (NHMRC) Ideas Grants, with seven projects receiving funding.…  Read more

A/Prof Pouya Faridi and his team has received funding from Pankind for his crucial work on immune therapies for pancreatic cancer research. …  Read more

Hudson Institute researchers have had some great success in the recent NHMRC Ideas and ARC Discovery Grant rounds.…  Read more

Associate Professor Dan Gough and his team are studying how to make these cold tumours visible to the immune system and prevent them spreading to other parts of the body.…  Read more

Associate Professor Dan Gough and his team have developed sophisticated models of lung cancer which allow them to model disease progression and observe response to current treatments in patients.…  Read more

Associate Professor Daniel Gough has received the first ever PASO Fellowship at Hudson Institute, securing the future of his ground-breaking lung cancer research.…  Read more

Ten years of research has revealed a vital secret to how cancer cells work, and opened the door to potential new treatments.…  Read more

Hudson Institute’s Research Committee has announced this year’s recipients of the Science Innovation Seed Funding Awards.…  Read more

Researchers at Hudson Institute of Medical Research have shown a new drug that is incredibly effective in treating small cell lung cancer – doubling the usual survival time.…  Read more

Pancreatic cancer is predicted to be the second leading cause of cancer-related death by 2030. While other cancer survival rates are improving, pancreatic cancer has been virtually unchanged for four decades.…  Read more

A new understanding of the causes of small cell lung cancer (SCLC) could lead to more personalised treatments and lower mortality from this deadly disease.…  Read more

Researchers looking into one of the deadliest forms of cancer have made a big breakthrough by drilling down to the molecular level.…  Read more

Hudson Institute researchers Dr Daniel Croagh and Professor Brendan Jenkins have  received a share of the Australian Pancreatic Cancer Foundation’s (PanKind) 2020 Collaborative Research Grant to help accelerate…  Read more

Hudson Institute scientists have discovered the key to how cells turn on inflammation and fight infection, providing the knowledge to potentially reduce or stop destructive inflammation in the future.…  Read more

Five Hudson Institute researchers have been awarded one-year Medicine/Science grants totalling nearly $300,000 by The CASS Foundation, to advance their research projects into mitochondrially-driven cancers, ovarian cancer, Parkinson’s disease, primary aldosteronism and endometriosis in 2020.…  Read more

Congratulations to Dr Daniel Gough for receiving a Mid-Career Research Fellowship from the Victorian Cancer Agency (VCA) for his research in developing new therapies for small cell lung cancer (SCLC).…  Read more

Hudson Institute researchers discover why the most common form of childhood brain cancer is seen in boys more than girls, and identify a potential biomarker for less aggressive treatment.…  Read more

Hudson Institute scientists will share expertise with leading international research institutions to progress research and improve treatments for children and adolescents with brain cancer. Hudson Institute has been announced as the first Australian member of the US-based Children’s Brain Tumor Tissue Consortium (CBTTC) and joins a collaborative, multi-institutional research program dedicated to the study and…  Read more

Investigating the role of the immune system in the fight against pancreatic cancer is the focus of innovative research at Hudson Institute, thanks to new funding announced on World Pancreatic Cancer Day.…  Read more

A team of scientists and clinicians in Clayton, Melbourne, has optimised a non-invasive technique to screen pancreatic cancer patients for responsiveness to specific drugs, and has commenced a trial with a drug currently used to treat colon cancer in the hope it may be effective in treating up to 10 per cent of pancreatic cancer patients.…  Read more

MIMR-PHI cancer researchers, Drs George Grigoriadis and Daniel Gough were among 25 scientists recently awarded VCA funding.…  Read more